Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

409 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Plasma Concentrations and Safety of Lopinavir/Ritonavir in COVID-19 Patients.
Chouchana L, Boujaafar S, Gana I, Preta LH, Regard L, Legendre P, Azoulay C, Canouï E, Zerbit J, Carlier N, Terrier B, Kernéis S, Batista R, Treluyer JM, Zheng Y, Benaboud S. Chouchana L, et al. Among authors: treluyer jm. Ther Drug Monit. 2021 Feb 1;43(1):131-135. doi: 10.1097/FTD.0000000000000838. Ther Drug Monit. 2021. PMID: 33230045 Free PMC article.
Influence of body weight on achieving indinavir concentrations within its therapeutic window in HIV-infected Thai patients receiving indinavir boosted with ritonavir.
Cressey TR, Urien S, Hirt D, Halue G, Techapornroong M, Bowonwatanuwong C, Leenasirimakul P, Treluyer JM, Jourdain G, Lallemant M; PHPT-3 Team. Cressey TR, et al. Among authors: treluyer jm. Ther Drug Monit. 2011 Feb;33(1):25-31. doi: 10.1097/FTD.0b013e3182057f6f. Ther Drug Monit. 2011. PMID: 21233689 Free PMC article.
Evaluation of nevirapine dosing recommendations in HIV-infected children.
Foissac F, Bouazza N, Frange P, Blanche S, Faye A, Lachassinne E, Dollfus C, Hirt D, Benaboud S, Treluyer JM, Urien S. Foissac F, et al. Among authors: treluyer jm. Br J Clin Pharmacol. 2013 Jul;76(1):137-44. doi: 10.1111/bcp.12069. Br J Clin Pharmacol. 2013. PMID: 23278548 Free PMC article.
Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial.
Tubiana R, Mandelbrot L, Le Chenadec J, Delmas S, Rouzioux C, Hirt D, Treluyer JM, Ekoukou D, Bui E, Chaix ML, Blanche S, Warszawski J; ANRS 135 PRIMEVA (Protease Inhibitor Monotherapy Evaluation) Study Group. Tubiana R, et al. Among authors: treluyer jm. Clin Infect Dis. 2013 Sep;57(6):891-902. doi: 10.1093/cid/cit390. Epub 2013 Jun 12. Clin Infect Dis. 2013. PMID: 23766338 Clinical Trial.
409 results